COVID-19 Outbreak-Global Point-of-Care Diagnostics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

The point of Care Diagnostics is medical testing performed at the clinical laboratory in close proximity to where the patient is receiving care. POCT is usually performed by non-laboratory persons and the results are used for clinical decision making. Point- of-care technologies may enhance the management of different diseases and conditions. The point of Care diagnostics is of great importance in developing countries. Unfortunately, a major aspect in developing countries is that they often lack modern laboratories, fully automated instruments that provide highly reproducible, quantitative, and hence sensitive and accurate diagnostic results. In order to circumvent these issues, the emergence of rapid and easy-to-use point-of-care (POC) tests can dramatically enhance a physician’s ability to diagnose patients’ diseases rapidly and accurately.
The Point-of-Care Diagnostics market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Point-of-Care Diagnostics industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Point-of-Care Diagnostics market can be split based on product types, major applications, and important countries as follows:

Key players in the global Point-of-Care Diagnostics market covered in Chapter 12:
Bayer
Nipro
Roche Diagnostics
Abbott Laboratories
Becton Dickinson
Johnson & Johnson
Danaher Corporation
Abaxis
Alere
Siemens Healthcare
Samsung Medison

In Chapter 4 and 14.1, on the basis of types, the Point-of-Care Diagnostics market from 2015 to 2025 is primarily split into:
Prescription-Based Testing Kits
Over-The-Counter Testing Kits

In Chapter 5 and 14.2, on the basis of applications, the Point-of-Care Diagnostics market from 2015 to 2025 covers:
Home
Hospitals
Ambulatory Care

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025